Pharma Reviews: Torrent Pharma slips 6% on profit-booking; outlook remains a concern

Though the company remains confident of outperforming Indian pharmaceutical market growth, analysts at Dolat Capital remain wary of the exports ...
Read more: Torrent Pharma slips 6% on profit-booking; outlook remains a concern